]>
IRCT20100420003760N4 IRCT 2020-07-29 Khoram-Abad University of Medical Sciences Compare the effectiveness of betamethasone and lavender and peppermint in reducing the severity of symptoms in patients with eczema and psoriasis Compare the effectiveness of betamethasone and lavender and peppermint in reducing the severity of symptoms in patients with eczema and psoriasis 2017-01-19 anticipated 120 Complete https://irct.ir/trial/3869 interventional Randomization: Not randomized, Blinding: Triple blinded, Placebo: Used, Assignment: Parallel, Purpose: Supportive, Blinding description: Patients, physicians, questioners, and data analysts associated with the study outcome are unaware of the codes associated with each formulation. The researcher is not involved in this process. The drugs were placed in envelopes and given to the doctor. 2 Condition 1: eczema and psoriasis. Condition 2: Psoriasis. Intervention 1: Intervention group: receive the essential oil of Lavendula ooficinalis 3 % b.i.d Up to two weeks. Intervention 2: Intervention group: receive the essential oil of Lavendula ooficinalis 5 % b.i.d Up to two weeks. Intervention 3: Intervention group: receive the essential oil of Lavendula ooficinalis 7 % b.i.d Up to two weeks. Intervention 4: Control group: receive Eucerin b.i.d Up to two weeks. Intervention 5: Control group: receive Betamethasone b.i.d Up to two weeks. Intervention 6: Intervention group: receive the essential oil of Menthe piperita 5% b.i.d Up to two weeks. Intervention 7: Intervention group: receive the essential oil of Menthe piperita 7 % b.i.d Up to two weeks. Intervention 8: Intervention group: receive the essential oil of Menthe piperita 3% b.i.d Up to two weeks. Yes - There is a plan to make this available What will be shared: Only part of the data, such as information about the main consequence or similar, can be shared. When: Start the access period 18 months after printing the results. To whom: Data will only be available to researchers working at academic and scientific institutions. Conditions: The data will only be used to inform the results of the study. Where to obtain: Lorestan University of Medical Sciences. How to obtain: Refer to Lorestan University of Medical Sciences. Comments:
public Marzieh Rashidipour
Lorestan University of Medical Sciences, Anooshirvan Rezaei Square, Khorramabad, Lorestan, Iran.
Khorramabad Iran (Islamic Republic of) 6814989468 +98 66 3320 4005 m_rashidi80@yahoo.com Lorestan University of Medical Sciences scientific Marzieh Rashidipour
Lorestan University of Medical Sciences, Anooshirvan Rezaei Square, Khorramabad, Lorestan, Iran.
Khorramabad Iran (Islamic Republic of) 6814989468 +98 66 3312 0172 m_rashidi80@yahoo.com Lorestan University of Medical Sciences, Anooshirvan Rezaei Square, Khorramabad, Lorestan, Iran. Iran (Islamic Republic of) Inclusion criteria: The study population of men and women over the age of 10 with eczema or psoriasis who have been referred to the nomadic hospital since the beginning of the fall of 2016 for one year. 10 years 90 years Both Patients who have had a corticosteroid injection or have taken other oral or topical medications will be excluded. L40.9, L85 L40.9, L85 Dry skin dermatitis, Psoriasis, unspecified Dry skin dermatitis, Psoriasis, unspecified Treatment - Drugs Treatment - Drugs Treatment - Drugs Placebo Treatment - Drugs Treatment - Drugs Treatment - Drugs Treatment - Drugs Intervention group: receive the essential oil of Lavendula ooficinalis 3 % b.i.d Up to two weeks Intervention group: receive the essential oil of Lavendula ooficinalis 5 % b.i.d Up to two weeks Intervention group: receive the essential oil of Lavendula ooficinalis 7 % b.i.d Up to two weeks Control group: receive Eucerin b.i.d Up to two weeks Control group: receive Betamethasone b.i.d Up to two weeks Intervention group: receive the essential oil of Menthe piperita 5% b.i.d Up to two weeks Intervention group: receive the essential oil of Menthe piperita 7 % b.i.d Up to two weeks Intervention group: receive the essential oil of Menthe piperita 3% b.i.d Up to two weeks Scaly. Timepoint: 0,7,14. Method of measurement: Questionnaire. Painful. Timepoint: 0,7,14. Method of measurement: Questionnaire. Itching. Timepoint: 0,7,14. Method of measurement: Questionnaire. Skin lesions. Timepoint: 0,7,14. Method of measurement: Questionnaire. Swelling. Timepoint: 0,7,14. Method of measurement: Questionnaire. Redness of the skin. Timepoint: 0,7,14. Method of measurement: Questionnaire. Skin irritation. Timepoint: Days 1,7,14. Method of measurement: Questionnaire. Khoram-Abad University of Medical Sciences Approved 2016-12-26 Lorestan University of Medical Sciences Ethics Committee Lorestan university medical of sciences Khorramabad Lorestan Iran (Islamic Republic of)